Ghent University Academic Bibliography

Patient- versus physician-reported outcomes in prostate cancer patients receiving hypofractionated radiotherapy within a randomized controlled trial

Elke Rammant (UGent) , Piet Ost (UGent) , Martijn Swimberghe (UGent) , Barbara Vanderstraeten (UGent) , Nicolaas Lumen (UGent) , Karel Decaestecker (UGent) , Renée Bultijnck (UGent) , Gert De Meerleer (UGent) , Camille Sarrazyn, Roos Colman (UGent) , et al.

(2019) STRAHLENTHERAPIE UND ONKOLOGIE. 195(5). p.393-401

Add to list

Evaluating the current place of radiotherapy as treatment option for patients with muscle invasive bladder cancer in Belgium

Valerie Fonteyne (UGent) , Elke Rammant (UGent) , Piet Ost (UGent) , Yolande Lievens (UGent) , Bart De Troyer, Sylvie Rottey (UGent) , Gert De Meerleer, Daan De Maeseneer (UGent) , Dirk De Ridder and Karel Decaestecker (UGent)

(2018) CLINICAL GENITOURINARY CANCER. 16(6). p.e1159-e1169

Add to list

4 Weeks versus 5 weeks of hypofractionated high-dose radiation therapy as primary therapy for prostate cancer : interim safety analysis of a randomized phase 3 trial

Valerie Fonteyne (UGent) , Camille Sarrazyn, Martijn Swimberghe (UGent) , Gert De Meerleer (UGent) , Elke Rammant (UGent) , Barbara Vanderstraeten (UGent) , Frank Vanpachtenbeke (UGent) , Nicolaas Lumen (UGent) , Karel Decaestecker (UGent) , Roos Colman (UGent) , et al.

(2018) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 100(4). p.866-870

Add to list

Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence : a prospective, randomized, multicenter phase II trial

Piet Ost (UGent) , Dries Reynders (UGent) , Karel Decaestecker (UGent) , Valerie Fonteyne (UGent) , Nicolaas Lumen (UGent) , Aurélie De Bruycker (UGent) , Bieke Lambert (UGent) , Louke Delrue (UGent) , Renée Bultijnck (UGent) , Tom Claeys, et al.

(2018) JOURNAL OF CLINICAL ONCOLOGY. 36(5). p.446-453

Add to list

Journal Article
A1
open access

Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer : a phase II trial

Valerie Fonteyne (UGent) , Piet Dirix, Sara Junius, Elke Rammant (UGent) , Piet Ost (UGent) , Gert De Meerleer (UGent) , Martijn Swimberghe (UGent) and Karel Decaestecker (UGent)

(2017) BMC CANCER. 17.

Add to list

Whole pelvis radiotherapy for pathological node-positive prostate cancer

Filip Poelaert (UGent) , Valerie Fonteyne (UGent) , Piet Ost (UGent) , Bart De Troyer, Karel Decaestecker (UGent) , Gert De Meerleer (UGent) , Pieter De Visschere (UGent) , Tom Claeys, Bert Dhondt (UGent) and Nicolaas Lumen (UGent)

(2017) STRAHLENTHERAPIE UND ONKOLOGIE. 193(6). p.444-451

Add to list

The independent oncological role for cytoreductive nephrectomy in metastatic renal cell carcinoma : prognostic features in the era of targeted therapies

Tom Claeys, Nicolaas Lumen (UGent) , Candy Kumps (UGent) , Marleen Praet (UGent) , Gert De Meerleer (UGent) , Sylvie Rottey (UGent) , Piet Ost (UGent) , Pieter De Visschere (UGent) , Geert Villeirs (UGent) , Valerie Fonteyne (UGent) , et al.

(2017) UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 35(4). p.152.e13-152.e22

Add to list

Androgen receptor gene copy number and protein expression in treatment-naïve prostate cancer

Filip Poelaert (UGent) , Candy Kumps (UGent) , Nicolaas Lumen (UGent) , Stéphanie Verschuere, Louis Libbrecht (UGent) , Marleen Praet (UGent) , Sylvie Rottey (UGent) , Tom Claeys, Piet Ost (UGent) , Karel Decaestecker (UGent) , et al.

(2017) UROLOGIA INTERNATIONALIS. 99(2). p.222-228

Add to list

Journal Article
A1
open access

Combined high dose radiation and pazopanib in metastatic renal cell carcinoma : a phase I dose escalation trial

Katrien De Wolf, Sylvie Rottey (UGent) , Karim Vermaelen (UGent) , Karel Decaestecker (UGent) , Nora Sundahl (UGent) , Lizzy De Lobel (UGent) , Els Goetghebeur (UGent) , Gert De Meerleer (UGent) , Nicolaas Lumen (UGent) , Valerie Fonteyne (UGent) , et al.

(2017) RADIATION ONCOLOGY. 12.

Add to list

Journal Article
A1
open access

Prospective comparison of F-18 choline PET/CT scan versus axial MRI for detecting bone metastasis in biochemically relapsed prostate cancer patients

Wouter Huysse (UGent) , Frederic Lecouvet, Paolo Castellucci, Piet Ost (UGent) , Valerie Lambrecht (UGent) , Carlos Artigas, Marie-Laurence Denis, Kathia De Man (UGent) , Louke Delrue (UGent) , Lennart Jans (UGent) , et al.

(2017) DIAGNOSTICS. 7(4).

Academic Bibliography

Patient- versus physician-reported outcomes in prostate cancer patients receiving hypofractionated radiotherapy within a randomized controlled trial

Evaluating the current place of radiotherapy as treatment option for patients with muscle invasive bladder cancer in Belgium

4 Weeks versus 5 weeks of hypofractionated high-dose radiation therapy as primary therapy for prostate cancer : interim safety analysis of a randomized phase 3 trial

Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence : a prospective, randomized, multicenter phase II trial

Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer : a phase II trial

Whole pelvis radiotherapy for pathological node-positive prostate cancer

The independent oncological role for cytoreductive nephrectomy in metastatic renal cell carcinoma : prognostic features in the era of targeted therapies

Androgen receptor gene copy number and protein expression in treatment-naïve prostate cancer

Combined high dose radiation and pazopanib in metastatic renal cell carcinoma : a phase I dose escalation trial

Prospective comparison of F-18 choline PET/CT scan versus axial MRI for detecting bone metastasis in biochemically relapsed prostate cancer patients

Contents

Support

Contact